Drug · DIN 02272091
EMTRIVA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since April 11, 2026; first marketed March 3, 2006.
- Drug Identification Number (DIN)
- 02272091
- Company (DIN owner)
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Capsule
- Route
- Oral
- Therapeutic class (ATC)
- Emtricitabine J05AF09
- Class
- Human
- Record last updated
- July 13, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| EMTRICITABINE | 200 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- May 20, 2009: NOC 10219New Drug Submission (NDS) · Manufacturer name change
- November 21, 2005: NOC 7621New Drug Submission (NDS)